Provider: View Press Release
Type: Link
Title: GSK presents promising new data for bepirovirsen, an investigational treatment for chronic hepatitis B | GSK
Description: GSK today announced interim results from the B-Clear phase IIb trial at the EASL International Liver Congress.
Provider: View Press Release
Type: Link
Title: GSK announces £1 billion R&D investment over ten years to get ahead of infectious diseases in lower-income countries | GSK
Description: GSK announced £1bn investment over ten years to accelerate R&D dedicated to infectious diseases
Provider: View Press Release
Type: Link
Title: GSK to present new data from the B-Clear phase IIb trial for bepirovirsen in chronic hepatitis B at the International Liver Congress 2022 | GSK
Description: GSK will present 12 abstracts at the European Association for the Study of the Liver’s International Liver Congress 2022.
Provider: View Press Release
Type: Link
Title: GSK announces positive pivotal phase III data for its respiratory syncytial virus (RSV) vaccine candidate for older adults | GSK
Description: GSK today announced positive headline results from a pre-specified efficacy interim analysis of the AReSVi 006 phase III trial.
Provider: View Press Release
Type: Link
Title: GSK announces US FDA approval of Priorix for the prevention of measles, mumps and rubella in individuals 12 months of age and older | GSK
Description: Priorix becomes an additional source of measles, mumps and rubella vaccine for US patients
Provider: View Press Release
Type: Link
Title: Update: Proposed demerger of the Consumer Healthcare business from GSK to form Haleon | GSK
Description: The proposed Demerger is the most significant corporate change for GSK in the last 20 years